Literature DB >> 15492504

Initiation of mRNA translation in oncogenesis: the role of eIF4E.

Lorenzo Montanaro1, Pier Paolo Pandolfi.   

Abstract

The eukaryotic initiation factor 4E (eIF4E) is a key regulator of protein translation whose function is activated by the Akt and Ras proto-oncogenic signal transduction pathways. eIF4E enhances the translation of mRNAs encoding several genes involved in tumorigenesis and acts as a proto-oncogene, in vitro, when overexpressed in immortalized cells. Importantly, eIF4E is frequently found overexpressed in human cancers of multiple histological origins. However, in vivo evidence of the eIF4E neoplastic potential was lacking until now. Here we discuss recent findings that demonstrate eIF4E's oncogenic role in vivo through direct genetic approaches in the mouse, and identify novel oncogenic functions for this initiation factor in cooperative tumorigenesis and response to therapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15492504     DOI: 10.4161/cc.3.11.1251

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  11 in total

1.  Deregulation of eIF4E: 4E-BP1 in differentiated human papillomavirus-containing cells leads to high levels of expression of the E7 oncoprotein.

Authors:  Kwang-Jin Oh; Anna Kalinina; No-Hee Park; Srilata Bagchi
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 2.  Nucleolus, ribosomes, and cancer.

Authors:  Lorenzo Montanaro; Davide Treré; Massimo Derenzini
Journal:  Am J Pathol       Date:  2008-06-26       Impact factor: 4.307

3.  Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP.

Authors:  Ivan Topisirovic; Nadeem Siddiqui; Vincent Leroux Lapointe; Matthias Trost; Pierre Thibault; Catherine Bangeranye; Serafin Piñol-Roma; Katherine L B Borden
Journal:  EMBO J       Date:  2009-03-05       Impact factor: 11.598

4.  Stability of eukaryotic translation initiation factor 4E mRNA is regulated by HuR, and this activity is dysregulated in cancer.

Authors:  Ivan Topisirovic; Nadeem Siddiqui; Slobodanka Orolicki; Lucy A Skrabanek; Mathieu Tremblay; Trang Hoang; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

5.  eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.

Authors:  Oshrat Attar-Schneider; Metsada Pasmanik-Chor; Shelly Tartakover-Matalon; Liat Drucker; Michael Lishner
Journal:  Oncotarget       Date:  2015-02-28

6.  eIF4A RNA Helicase Associates with Cyclin-Dependent Protein Kinase A in Proliferating Cells and Is Modulated by Phosphorylation.

Authors:  Maxwell S Bush; Olivier Pierrat; Candida Nibau; Veronika Mikitova; Tao Zheng; Fiona M K Corke; Konstantinos Vlachonasios; Laura K Mayberry; Karen S Browning; John H Doonan
Journal:  Plant Physiol       Date:  2016-07-07       Impact factor: 8.340

7.  Improved eIF4E binding peptides by phage display guided design: plasticity of interacting surfaces yield collective effects.

Authors:  Weizhuang Zhou; Soo T Quah; Chandra S Verma; Yun Liu; David P Lane; Christopher J Brown
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

8.  Identification and Characterization of an eIF4e DNA Aptamer That Inhibits Proliferation With High Throughput Sequencing.

Authors:  Wei Mei Guo; Kiat Whye Kong; Christopher John Brown; Soo Tng Quah; Hui Ling Yeo; Shawn Hoon; Yiqi Seow
Journal:  Mol Ther Nucleic Acids       Date:  2014-12-16       Impact factor: 10.183

Review 9.  Targeting MYC in cancer therapy: RNA processing offers new opportunities.

Authors:  Cheryl M Koh; Arianna Sabò; Ernesto Guccione
Journal:  Bioessays       Date:  2016-01-18       Impact factor: 4.345

10.  The RNA helicase, eIF4A-1, is required for ovule development and cell size homeostasis in Arabidopsis.

Authors:  Maxwell S Bush; Natalie Crowe; Tao Zheng; John H Doonan
Journal:  Plant J       Date:  2015-12       Impact factor: 6.417

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.